These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26718160)

  • 1. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Monitoring Disease Progression.
    Mai J; Lee VW; Lopez-Vargas P; Vladica P; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):565-571.e18. PubMed ID: 26718160
    [No Abstract]   [Full Text] [Related]  

  • 2. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Screening for Polycystic Kidney Disease.
    Rangan GK; Lee VW; Alexander SI; Patel C; Tunnicliffe DJ; Vladica P
    Semin Nephrol; 2015 Nov; 35(6):557-564.e6. PubMed ID: 26718159
    [No Abstract]   [Full Text] [Related]  

  • 3. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Imaging Approaches for Diagnosis.
    Mai J; Lee VW; Lopez-Vargas P; Vladica P
    Semin Nephrol; 2015 Nov; 35(6):538-544.e17. PubMed ID: 26718156
    [No Abstract]   [Full Text] [Related]  

  • 4. Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.
    Kline TL; Korfiatis P; Edwards ME; Bae KT; Yu A; Chapman AB; Mrug M; Grantham JJ; Landsittel D; Bennett WM; King BF; Harris PC; Torres VE; Erickson BJ;
    Kidney Int; 2017 Nov; 92(5):1206-1216. PubMed ID: 28532709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging progression in polycystic kidney disease.
    Perrone R
    N Engl J Med; 2006 May; 354(20):2181-3. PubMed ID: 16707757
    [No Abstract]   [Full Text] [Related]  

  • 6. Kidney and cystic volume imaging for disease presentation and progression in the cat autosomal dominant polycystic kidney disease large animal model.
    Yu Y; Shumway KL; Matheson JS; Edwards ME; Kline TL; Lyons LA
    BMC Nephrol; 2019 Jul; 20(1):259. PubMed ID: 31299928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging 3T and total fibrotic volume in autosomal dominant polycystic kidney disease.
    Lai S; Mastroluca D; Letizia C; Petramala L; Perrotta AM; DiGaeta A; Ferrigno L; Ciccariello M; D'Angelo AR; Panebianco V
    Intern Med J; 2018 Dec; 48(12):1505-1513. PubMed ID: 30043487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current diagnostic evaluation of autosomal dominant polycystic kidney disease.
    Wołyniec W; Jankowska MM; Król E; Czarniak P; Rutkowski B
    Pol Arch Med Wewn; 2008 Dec; 118(12):767-73. PubMed ID: 19202957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease.
    King BF; Torres VE; Brummer ME; Chapman AB; Bae KT; Glockner JF; Arya K; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
    Kidney Int; 2003 Dec; 64(6):2214-21. PubMed ID: 14633145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of the Imaging Techniques for Measuring Kidney and Cyst Volume in Establishing Autosomal Dominant Polycystic Kidney Disease Progression.
    Magistroni R; Corsi C; Martí T; Torra R
    Am J Nephrol; 2018; 48(1):67-78. PubMed ID: 30071518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.
    Torres VE; King BF; Chapman AB; Brummer ME; Bae KT; Glockner JF; Arya K; Risk D; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP;
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):112-20. PubMed ID: 17699395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal relevant radiology: radiologic imaging in autosomal dominant polycystic kidney disease.
    Rahbari-Oskoui F; Mittal A; Mittal P; Chapman A
    Clin J Am Soc Nephrol; 2014 Feb; 9(2):406-15. PubMed ID: 24370765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP).
    O'Neill WC; Robbin ML; Bae KT; Grantham JJ; Chapman AB; Guay-Woodford LM; Torres VE; King BF; Wetzel LH; Thompson PA; Miller JP
    Am J Kidney Dis; 2005 Dec; 46(6):1058-64. PubMed ID: 16310571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease.
    Bhutani H; Smith V; Rahbari-Oskoui F; Mittal A; Grantham JJ; Torres VE; Mrug M; Bae KT; Wu Z; Ge Y; Landslittel D; Gibbs P; O'Neill WC; Chapman AB;
    Kidney Int; 2015 Jul; 88(1):146-51. PubMed ID: 25830764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between renal function and the total kidney volume measured on imaging for autosomal dominant polycystic kidney disease: A systematic review and meta-analysis.
    Jo WR; Kim SH; Kim KW; Suh CH; Kim JK; Kim H; Lee JG; Oh WY; Choi SE; Pyo J
    Eur J Radiol; 2017 Oct; 95():56-65. PubMed ID: 28987699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal volume in children with ADPKD: size matters.
    Chapman AB; Guay-Woodford LM
    Clin J Am Soc Nephrol; 2009 Apr; 4(4):698-9. PubMed ID: 19339418
    [No Abstract]   [Full Text] [Related]  

  • 17. Feasibility of measuring renal blood flow by phase-contrast magnetic resonance imaging in patients with autosomal dominant polycystic kidney disease.
    Spithoven EM; Meijer E; Borns C; Boertien WE; Gaillard CA; Kappert P; Greuter MJ; van der Jagt E; Vart P; de Jong PE; Gansevoort RT
    Eur Radiol; 2016 Mar; 26(3):683-92. PubMed ID: 26162576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTOR inhibitors and autosomal dominant polycystic kidney disease.
    Levey AS; Stevens LA
    N Engl J Med; 2011 Jan; 364(3):287; author reply 287-9. PubMed ID: 21247327
    [No Abstract]   [Full Text] [Related]  

  • 19. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Diet and Lifestyle Management.
    Campbell KL; Rangan GK; Lopez-Vargas P; Tong A
    Semin Nephrol; 2015 Nov; 35(6):572-581.e17. PubMed ID: 26718161
    [No Abstract]   [Full Text] [Related]  

  • 20. Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
    Boertien WE; Meijer E; de Jong PE; ter Horst GJ; Renken RJ; van der Jagt EJ; Kappert P; Ouyang J; Engels GE; van Oeveren W; Struck J; Czerwiec FS; Oberdhan D; Krasa HB; Gansevoort RT
    Am J Kidney Dis; 2015 Jun; 65(6):833-41. PubMed ID: 25600953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.